Letter | Published:

IMP dehydrogenase, an enzyme linked with proliferation and malignancy

Naturevolume 256pages331333 (1975) | Download Citation

Subjects

Abstract

PREVIOUS studies conducted in this laboratory demonstrated that in a spectrum of liver tumours with different growth rates there is an imbalance in the activities of key enzymes and competing pathways of carbohydrate, pyrimidine, DNA and ornithine metabolism1–4. Recent investigations on purine metabolism showed that in the hepatomas there was an increased capacity in the de novo pathway of biosynthesis of inosine 5′-monophosphate (IMP), as reflected in the increased activity of glutamine PRPP amidotransferase (EC 2.4.2.14) and a decrease in IMP catabolism5,6. These observations directed our attention to the metabolic fate of IMP because this purine nucleotide is at a strategic position in purine metabolism (Fig. 1). Control at such branching points is exerted primarily by modification of the activity or of the rate of synthesis of the first enzymes of the divergent pathways. In this instance, in normal conditions, a balance is maintained by both positive and negative feedback effects. Thus ATP is required for GMP biosynthesis and GTP for AMP biosynthesis; conversely, GMP and AMP each inhibit their own production7. In normal or malignant proliferation, or in response to a hormone stimulus, changes in control frequently involve reprogramming of gene expression. The theoretical framework and predictive value of generalisations about such biochemical changes (termed the molecular correlation concept) have been elaborated1–3.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1

    Weber, G., in The Molecular Biology of Cancer (edit. by Busch, H.) 487–521 (Academic, New York, 1974).

  2. 2

    Weber, G., Queener, S. F., and Ferdinandus, J. A., Adv. Enzyme Regul., 9, 63–95 (1971).

  3. 3

    Weber, G., Adv. Enzyme Regul., 11, 79–102 (1973).

  4. 4

    Williams, J. C., Weber, G., and Morris, H. P., Nature, 253, 567–569 (1975).

  5. 5

    Katunuma, N., and Weber, G., FEBS Lett., 49, 53–56 (1974).

  6. 6

    Weber, G., Prajda, N., and Williams, J. C., Adv. Enzyme Regul., 13, 3–25 (1975).

  7. 7

    Hartman, S. C., in Metabolic Pathways, third ed., 4 (edit. by Greenberg, D. M.), 1–69 (Academic, New York, 1970).

  8. 8

    Abrams, R., and Bentley, M., Archs Biochem., 56, 184–195 (1955).

  9. 9

    Atkinson, M. R., Morton, R. K., and Murray, A. W., Biochem., J., 89, 167–172 (1963).

  10. 10

    Al-Mudhaffar, S., and Ackerman, C. J., Endocrinology, 82, 912–918 (1968).

  11. 11

    Pehlke, D. M., McDonald, J. A., Holmes, E. W., and Kelley, W. N., J. clin. Invest., 51, 1398–1404 (1972).

  12. 12

    Anderson, J. A., and Sartorelli, A. C., J. biol. Chem., 243, 4762–4768 (1968).

  13. 13

    McFall, E., and Magasanik, B., J. biol. Chem., 235, 2103–2108 (1969).

  14. 14

    Holmes, E. W., Pehlke, D. M., and Kelley, W. N., Biochim. biophys. Acta, 364, 209–217 (1974).

  15. 15

    Saccoccia, P. A., and Miech, R. P., Molec. Pharmac., 5, 26–29 (1969).

  16. 16

    Sweeney, M. J., Hoffman, D. H., and Esterman, M. A., Cancer Res., 32, 1803–1809 (1972).

  17. 17

    Cleland, W. W., Biochim. biophys. Acta, 67, 104–137 (1963).

  18. 18

    Bucher, N. L. R., and Malt, R. A., Regeneration of Liver and Kidney (Little, Brown, Boston, 1971).

Download references

Author information

Affiliations

  1. Laboratory for Experimental Oncology and Department of Pharmacology, Indiana University School of Medicine, Indianapolis, Indiana, 46202

    • ROBERT C. JACKSON
    •  & GEORGE WEBER
  2. Department of Biochemistry, Howard University College of Medicine, Washington, DC, 20001

    • HAROLD P. MORRIS

Authors

  1. Search for ROBERT C. JACKSON in:

  2. Search for GEORGE WEBER in:

  3. Search for HAROLD P. MORRIS in:

About this article

Publication history

Received

Accepted

Issue Date

DOI

https://doi.org/10.1038/256331a0

Further reading

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.